Prostate-specific antigen nadir after high-dose-rate brachytherapy predicts long-term survival outcomes in high-risk prostate cancer

PURPOSE: To evaluate the prognostic value of prostate-specific antigen nadir (nPSA) after high-dose-rate (HDR) brachytherapy in clinically non-metastatic high-risk prostate cancer patients. MATERIAL AND METHODS: Data from 216 patients with high-risk or locally advanced prostate cancer who underwent...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Contemp Brachytherapy
Autores principales: Tsumura, Hideyasu, Satoh, Takefumi, Ishiyama, Hiromichi, Tabata, Ken-ichi, Komori, Shouko, Sekiguchi, Akane, Ikeda, Masaomi, Kurosaka, Shinji, Fujita, Tetsuo, Kitano, Masashi, Hayakawa, Kazushige, Iwamura, Masatsugu
Formato: Artigo
Lenguaje:Inglês
Publicado: Termedia Publishing House 2016
Materias:
Original Paper
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4873555/
https://ncbi.nlm.nih.gov/pubmed/27257412
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/jcb.2016.59686
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares